H1
PrivateLast Round
Series D
May 28, 2026
Est. Valuation
$773M
Total Funding Raised
$250.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
H1 is a healthcare technology company that provides an AI-driven platform for identifying and engaging healthcare professionals, organizations, and clinical research data.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Clinical Trials, Business Intelligence, Vertical SaaS, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
H1 Comparables
Compare H1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Norstella | 83% | |
| Komodo Health | 82% | |
| Valsoft Corporation | 81% |
H1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 28, 2026 | ||||
| Series C Extension | Jun 9, 2022 | ||||
| Series C | Nov 16, 2021 | ||||
| Series B | Dec 17, 2020 | ||||
| Series A | Apr 22, 2020 | ||||
Accelerator | Jan 1, 2020 |
H1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| dRx Capital | Series C |
| Lux Capital | Series C, Series B |
| Lead Edge Capital | Series C, Series B |
| ClearPoint Investment Partners | Series A |
| Y Combinator | Series C, Series A, Series B, Accelerator |
| Underscore VC | Series A |
| CVS Health Ventures | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2026
$40M round led by CVS Health Ventures.
- Jun 9, 2022
$33M round with participation from Menlo Ventures and Novartis.
H1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about H1's valuation, stock price, and market status.
Is H1 a public or private company?
H1 is a private company.
What is the current stock price of H1?
H1 is a private company with no public stock price. Caplight tracks H1's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is H1 worth (valuation)?
H1's valuation is estimated at $773.0M based on funding round data.
Can I buy H1 stock?
H1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was H1's last funding round?
H1's most recent funding round was Series D on June 9, 2022.
Who are the main investors in H1?
Key investors in H1 include Y Combinator, CVS Health Ventures, Institutional Venture Partners (IVP), Menlo Ventures, Altimeter Capital Management.
Will H1 IPO soon?
No public IPO plans have been announced for H1.
How can I track H1 secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor H1's secondary market activity and sign up for updates.